Patent: 10,473,640
✉ Email this page to a colleague
Summary for Patent: 10,473,640
Title: | Drug selection for gastric cancer therapy using antibody-based arrays |
Abstract: | The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer. |
Inventor(s): | Singh; Sharat (Rancho Santa Fe, CA), Kim; Phillip (Irvine, CA), Liu; Xinjun (San Diego, CA), Ybarrondo; Belen (San Diego, CA) |
Assignee: | Societe des Produits Nestle S.A. (Vevey, CH) |
Application Number: | 13/014,674 |
Patent Claims: | see list of patent claims |
Details for Patent 10,473,640
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2026-09-21 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2026-09-21 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2026-09-21 |
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 05/07/2001 | ⤷ Try a Trial | 2026-09-21 |
Genzyme Corporation | LEMTRADA | alemtuzumab | Injection | 103948 | 11/14/2014 | ⤷ Try a Trial | 2026-09-21 |
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 10/12/2004 | ⤷ Try a Trial | 2026-09-21 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |